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Summary
he autonomic nervous s1'stem controls many aspects of airway function,
including airway smooth muscle tone, mucus secretion, and intra-
pulmonary vascuiar permeabil ity and blood flow. The predominant
control is provided by parasympathetic nerves, using acetylcholine (ACh) as the
neurotransnitter, to give bronchoconstriction, enhanced mucus secretion, and
bronchial vasodilatation. Sympathetic innervation, using noradrenaline (NA) as
the neut'otransmitter, is generally much sparser. Sympathetic neurotransmission
causes inhibit ion of mucus secretion, bronchial vasoconstriction, and relaxation of
airway smooth ntuscle. In addition to these classic components of the autonomic
nervous system, airways receive non-adlenergic non-cholinergic (NANC) input.
This thesis focuses on the prejunctional auto- and heteroregulation of
neurotransmittel release from cholinergic and adrenergic nerves innervating the
airways. Electrical f ield stimr.rlation (EFS)-induced simultaneous release of
endogenous ACh and NA release from airway autonomic neïves were measured
using two sensitive HPLC systems equipped with electrochemical detection. This
method enabled us to study directly the control of neurotransmitter release via
prejuncLional muscarinic and adrenergic receptors in guinea pig as well as in
human ai rway p leparat ions.
In epithelium-denuded guinea pig tracheal section, EFS ftiphasic square
wave pulses. 16 Hz, 150 mA, 0.8 ms, for 5 min) evoked the release of ACh [29
pmol x (g tissue) 1 x (5 min) i l  and NA [70 pmol x (g tissue) I 
" 
(5 min) t]. This
release appeared under the ouloinhibitory control of muscarinic and ctz-
adlenergic receptors, respectively, as indicated by an increased ACh and NA
release after incubation with the muscarinic and crz-adrenoceptor antagonists
atropine and yohirnbine (chapter 2). In addition to this autoregulation, we
established that endogenously released ACh and NA also controlled each other's
release ujcr prejunctional muscarinic and crz-adrenergic heteroreceptors. This was
shown in experiments in which the blockade of prejunctional muscarinic
receptors resulted in a clearly enhanced release of both ACh and NA. An
adrenergic control of ACh release through crz-adrenergic heteroreceptors was
demon-qtrated by a yohimbine-induced augmentation of ACh release, but, only
uncler conditions of elevated, synapt,ic NA levels, i.e. after blocking NA reuptake





adrenergic autoreceptors weïe maximally activated by endogenously released
NA; only at lower stimulation frequencies (2-4 Hz) the ctz-adrenoceptoï agonist
clonidine was able to induce an inhibition of evoked ACh and NA release. The
existence of prejunctional heteroregulation of neurotransmitter release might
have clinical importance with respect to asthma, because the presumed
dysfunction of muscarinic autoreceptors on cholinergic nerves, resulting in
elevated ACh levels in asthmatic airways, could also lead to a reduction of NA
release, shift ing the smooth muscle contraction/relaxation balance even further
to the contractile side.
In a subsequent study we investigated the functional implications of the
prejunctional auto- and heteroregulation of neurotransmitter release as
described above (chapter 3). EFS ftiphasic square wave pulses, 16 Hz, 150 mA,
0.8 ms, for 4 sec with intervals of 80 sec) was used to elicit twitch contractions
and relaxations of single epithelium-denuded open-ring preparations of guinea
pig tracheae. The EFS-induced twitch contractions consisted solely of muscarinic
Ms receptor-mediated cholinergic responses, while lelaxant responses mainly
involved timolol-sensitive adrenergic neurotransmission (-70%) and inhibitory
non-adrenergic non-cholinergic neurotransmission (-30%), sensitive to the nitric
oxide synthase rnhibitor L-NAME. In agreement with our release experiments,
both the cholinergic twitch response and the adrenergic component of the
relaxant response weÍe under clear inhibitory control of prejunctional
autoreceptors of the muscarinic Mz and the crz-adrenergic subtype, respectively.
The crz-adrenergic heteroreceptors played a minor role in the control of the
cholinergic contraction. In contrast to release data, muscarinic Mz
heteroreceptors were not of any significance in the control of the NA- (and NO-)
mediated component of the relaxation. This discrepancy may lead to the
assumption that the muscarinic heteroreceptor in the guinea pig trachea is of
pharmacologically distinct subtype (i.e., more'Mz-like'than classic Mz) with a
lower affinity towards muscarinic M2 receptor antagonists. There may also be
threshold-effects in the activation of the heteroreceptor. The concentration of
released ACh may exceed the threshold-activation-level of the muscarinic
heteroreceptors in release but not functional experiments. In the presence of L-
NAME, but not of timolol, the twitch contraction was significantly enhanced,
indicating functional antagonism by NO, but not NA, of the cholinergic response.
Another interesting finding was that blockade of muscarinic Mz heteroreceptors
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resulted in a strongly enhanced inhibitory function of crz-adrenergic
autoreceptors, as revealed by the exaggerated 2.5-fold potentiation of the
lelaxant response by yohimbine. This might indicate that these receptors share
common Gi-proteins; blockade of one inhibitory receptor enhances the availability
of Gi to the other inhibitory receptor.
The presence ancl function of prejunctional Bz-adrenoceptors in guinea pig
airways were studied in chapter 4. Preincubation with the Bz-adrenoceptor
agonist fenoterol resulted in a clear facilitation of EFS-evoked ACh and NA
release, an effect that could be abolished completely by the Bz-adrenoceptor
antagonist ICI 118,551. Prejunctional Bz-adrenoceptors on adrenergic nerve
endings showed a strong facil i tation of NA release (up to -500% of control) that
was concentration-dependent (0.1-100 pM fenoterol). The observation that the
facil i tatory effect diminished with longer agonist contact-times (1-15 min)
indicated that pz-adrenoceptors on adrenergic nerve endings are readily
susceptible to desensitization. By contrast, sensitivity to fenoterol on cholinergic
nerve terminals increased when the incubation period was prolonged; in addition,
a bell-shaped concentration-response relationship was found at 15 min
incubation. The results showed that Bz-adrenoceptors on cholinergic and
adrenergic nerve endings possess different characteristics both with respect to
their capacity to facilitate neurotransrnitter release and their susceptibility to
desensitization.
The differential facil i tatory responses of prejunctional pz-adrenoceptors on
the two types of atrtonomic nerves as described above, indicated us to take a
closer look at the signal transduction mechanisms of these receptors (chapter 5).
To investigate the involvement of cyclic AMP (cAMP) in the Bz-adrenoceptor-
mediated facil i tation of neurotransmitter release, the direct activator of adenylyl
cyclase, forskolin, was used. Forskolin (0.1-100 ;rM) induced a concentration-
dependent augmentation of ACh release (to 195% of control), but not of NA
lelease, to our ,surprise. This would indicate that, in contrast to cholinergic
neïves, pz-adrenoceptors on adrenergic nerve endings do not mediate their
facilitatory effects uia actívation of the adenylyl cyclase pathway. As an
alternative mode we considered a cAMP-independent activation of Ca2* channels,
since influx of Ca2* ions is the actual trigger for exocytotic neurotransmitter
release from nerve endings. In the presence of nifedipine, neither control release
nor the fenoterol-incluced facil i tation of NA (and of ACh) release \Mere changed,
Summarv
indicating that L-type Ca2* channels are not involved at all. When control release
was diminished by preincubation with <o-conotoxin G\IIA, a selective N-type Caz+
channel antagonist, the capacity of fenoterol to facil i tate NA release was
markedly enhanced, surprisingly. At f irst sight, this would suggest the presence
of an additional transduction mode ofprejunctional p:-adrenoceptors to facil i tate
neuronal Ca2+ influx (or mobilization) in adrenergic nerve terminals. However,
when control NA release was dimished to a similar extent by lowering the
stimulation frequency from 16 Hz to 4 Hz, the facilitation by fenoterol was also
enhanced, by approximately the same fac1,or. Collectively, the results suggest
different signal transduction modes of prejunctional Bz-adrenoceptors to be
operative in adrenergic and cholinergic nerve terminals.
Using tube preparations of human intrapulmonary bronchi, we were able
to show for the first time that in addition to ACh [18 prnol x (g tissue)-l x (5 min)-
rl, also endogenous NA [55 pmol x (g tissue)-1 x (5 min)'1] was released when the
preparations were subjected to electrical f ield stimulation (chapter 6). Release of
both neurotransmitters was inhibited after administration of 1 pM TTX,
indicating the neuronal origin of both ACh and NA. Since pz-adrenoceptor
mediated facil i tation has not been reported previously in human bronchi, we
studied the putative prejunctional effects of fenoterol on the release of the two
transmitters. Analogous to the results obtained with guinea pig tracheae, EFS-
evoked lelease of both ACh and NA was facil i tated after incubation with
fenoterol (1-100 prM, 15 min preincubation). The highest concentration of
fenoterol augmented ACh release to 1.48% of control, while the simultaneous
release of NA was augmented to 185%. Preincubation with the Bz-adrenoceptor
zrntagonist ICI 118,551 abolished the fenoterol-inducecl facil i tation of both ACh
and NA release. Although sympathetic nerves sparsely innervate human airway
musculature directly, the released NA may originate fron sympathetic nerves
projecting to subepithelial blood vessels, bronchial glands and the blood vessels of
these glands. A clinical implication of these findings might be that in addition to
postjunctional airway smooth muscle relaxation, Bz-adrenoceptor agonists may
reduce mucosal congestion by enhancing NA release from sympathetic nerve
endings. These beneficial effects may overrule the adverse effect of enhanced
ACh release from parasympathetic nelves.
The endogenous agonists for prejunctional Bz-adrenoceptors may be
circulating adrenaline derived from the adrenal medulla and to some extent NA
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released from local sympathetic nerves. In chapter 7 we have investigated
whether sympathetic nerves innervating the guinea pig trachea can take up,
store, and release adrenaline as a co-transmitter of NA, and to which extent co-
released adrenaline is able to facil i tate the release of endogenous NA and ACh.
Preincubation of the tissue with adrenaline (0.1-1.0 pM) followed by washing
resulted in a desipramine-sensitive uptake and storage into, and in subsequent
EFS-induced co-release of adrenaline from the sympathetic nerves. Init ial release
of adrenaline (up to IL7% compared to control NA release) was always
accompanied by a reduction in NA release, while total catecholamine release was
enhanced. This increase could not be attributed to activation of prejunctional crz-
or Bz-adrenoceptors, respectively, since the patterns of adrenaline and NA release
were not altered after yohimbine or ICI 118,551. Protection of the prejunctional
Bz-adrenoceptors from putative desensitization during adrenaline-loading, using
the hydrophilic p-adrenoceptor antagonist sotalol, did not further enhance
catecholamine release. Combined with the data in Chapter 4 showing that
prejunctional pz-adrenoceptors with marked facil i tatory capacity ore present on
sympathetic nerves of the guinea pig trachea, the results indicate that these
receptors are not localized in close proximity to the exocytotic release sites of the
varicosities. Evoked release of ACh was not affected by adrenaline preloading
and subsequent EFS-induced co-release, indicating that adrenaline co-released
from sympathetic nerves may not reach the prejunctional pz-heteroreceptors on
cholinergic nerves either. Nevertheless, the results suggest that due to enhanced
half-l i fe as a result of intraneuronal storage, adrenaline released as a co-
transmitter of I.trA might increase the sympathetic control over those structures
in the airways that receive adrenergic innervation.
MIIN CoNCLUSIONS
he evoked release of ACh and NA from autonomic nerves in the guinea
pig trachea is not only subject to prejunctional inhibitory ouloregulation
but also to inhibitory heteroregulation uía az-adtenergic and muscarinic
acetylcholine receptors. However, only the prejunctional muscarinic Mz and crz-
adrenergic autoreceptors control postjunctional cholinergic contractions and





by prejunctional oz-receptors is under marked additional
Mz-heteroreceptors; in contrast, there is only a minor
prejunctional az-heteroreceptors.
n guinea pig trachea and human bronchus, evoked release of both ACh and
NA is under facilitatory control ofprejunctional Bz-adrenoceptors. Especially
the receptors on adrenergic nerve endings have a strong capacity to facil i tate
NA release, which -in the guinea pig trachea- are subject to desensitization,
however. The facil i tatory effect of prejunctional pz-adrenoceptors on cholinergic
nerve endings is mediated through activation of the cAMP-cascade pathway,
whereas the signaling in adrenergic nerve endings is cAMP-independent. In
addition to postjunctionally mediated relaxation of airway smooth muscle,
inhaled Bz-adrenoceptor agonists as well as adrenaline taken up into and
released as a cotransmitter from sympathetic varicosities, may have
bronchodilatory effects by enhancing sympathetic nerve output, consequently
reducing mucosal congestion and edema.
